Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Biomaterials. 2012 Aug 24;33(33):8632–8640. doi: 10.1016/j.biomaterials.2012.08.005

Fig. 6.

Fig. 6

Transaminases in mice treated with nanoparticles. Mice were injected with one (1×), two (2×), or three (3×) doses of αvβ3-Ctrl NPs or αvβ3-Fum-PD NPs. Three days after the last injection, samples were drawn and serum levels of aspartate aminotransferase (AST, a) and alanine aminotransferase (ALT, b) were assessed. Values represent mean ± SEM, n = 9 animals in the no treatment (Tx) group and 4–6 animals per treatment group. *P < 0.01 compared with no Tx.